Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Adjusting the dose of triple therapy (Elexacaftor/Tezacaftor/Ivacaftor) to reduce mental health side effects

Adjusting the dose of triple therapy (Elexacaftor/Tezacaftor/Ivacaftor) to reduce mental health side effects

Resource Type

CF Research News

Authors

Spoletini G, Gillgrass L, Pollard K, Shaw N, Williams E, Etherington C, Clifton Ij, Peckham Dg

References

J Cyst Fibros. 2022 May 15;S1569-1993(22)00111-4. doi: 10.1016/j.jcf.2022.05.001. Online ahead of print.
 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Psychosocial [4]
Pulmonology [5]

Date

Sunday, May 15, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/adjusting-dose-triple-therapy-elexacaftortezacaftorivacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-22-00036R2_FINAL_Peckham_210522.pdf [2] https://pubmed.ncbi.nlm.nih.gov/35585012/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/psychosocial [5] https://www.ecfs.eu/research-article-themes/pulmonology [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines